Article(id=1325223810647065142, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223782998213020, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2026.04.012, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1736524800000, receivedDateStr=2025-01-11, revisedDate=1746979200000, revisedDateStr=2025-05-12, acceptedDate=null, acceptedDateStr=null, onlineDate=1793887577926, onlineDateStr=2026-11-05, pubDate=1775750400000, pubDateStr=2026-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793887577926, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793887577926, creator=13701087609, updateTime=1793887577926, updator=13701087609, issue=Issue{id=1325223782998213020, tenantId=1146029695717560320, journalId=1319690329412173987, year='2026', volume='47', issue='4', pageStart='341', pageEnd='454', issueExtLink='null', onlineDate='null', pubDate='1775750400000', pubDateStr='2026-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793887571333, creator='13701087609', updateTime=1793934805900, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325421899181858923, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223782998213020, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325421899181858924, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223782998213020, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=425, endPage=434, ext={EN=ArticleExt(id=1325223810902917687, articleId=1325223810647065142, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=The application and prospects of chimeric antigen receptor T cell therapy in pediatric diseases, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=
Chimeric antigen receptor T cell therapy(CAR-T cell therapy) is a revolutionary cell-based immunotherapy technique that has initiated innovative exploration and clinical practice in pediatric medicine, bringing therapeutic hope to children with refractory and severe diseases. However, it may be accompanied by adverse reactions, which remains a key issue to be focused on in current research and clinical application. This paper comprehensively reviewed the latest research progress of CAR-T cell therapy at home and abroad, systematically summarized the application status of this therapy in pediatric hematological malignancies, solid tumors, and autoimmune diseases, and conducted in-depth analysis of its mechanism, providing a reference for clinical practice.
, authors=Danqing HU
1, Chan HUANG
2, Yuwei LU
3, Xinghao JIN
4a, Zibin BU
4b, Wei ZHOU
4c, *, authorsList=Danqing HU, Chan HUANG, Yuwei LU, Xinghao JIN, Zibin BU, Wei ZHOU, authorCompany=null, correspAuthors=Wei ZHOU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325223811234267704, articleId=1325223810647065142, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=嵌合抗原受体T细胞治疗在儿童疾病中的应用与展望, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=
嵌合抗原受体T细胞治疗(chimeric antigen receptor T cell therapy,CAR-T cell therapy)是一种革命性的细胞免疫治疗技术,目前已在儿科领域开启创新探索与临床实践,为疑难重症患儿带来治疗希望。然而,CAR-T细胞治疗可能伴随不良反应,这是当前研究和应用中需重点关注的问题。现综合国内外CAR-T细胞治疗最新研究进展,系统概述该疗法在儿童血液系统肿瘤、实体瘤及自身免疫性疾病等疾病中的应用现状,对其机制进行深入分析,为临床提供参考。
, authors=胡丹青
1, 黄婵
2, 陆雨薇
3, 金星昊
4a, 卜梓斌
4b, 周维
4c, *, authorsList=胡丹青, 黄婵, 陆雨薇, 金星昊, 卜梓斌, 周维, authorCompany=null, correspAuthors=周维, authorNote=
, correspAuthorsNote=
周维,博士后,研究方向:儿童慢性肾脏病的免疫调控机制。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=/OfkoLhwmoaaiLsCUqHzMQ==, magXml=rlFEIewwSq8nBtxoIgIw2Q==, pdfUrl=null, pdf=aWYoDFAE3rRKcHw+NeopZw==, pdfFileSize=991017, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=2Pcb/Mm6feVdLMSZt2YYIg==, mapNumber=null, fund=null)}, authors=[Author(id=1325223813629215309, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223813729878607, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, authorId=1325223813629215309, language=EN, stringName=Danqing HU, firstName=Danqing, middleName=null, lastName=HU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.The Second Affiliated School of Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223813826347600, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, authorId=1325223813629215309, language=CN, stringName=胡丹青, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.浙江中医药大学第二临床医学院,浙江 杭州 310053, bio={"content":"
胡丹青,研究方向:儿童慢性肾脏病的免疫调控机制。
"}, bioImg=null, bioContent=
胡丹青,研究方向:儿童慢性肾脏病的免疫调控机制。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223812941349434, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, xref=1., ext=[AuthorCompanyExt(id=1325223812949738043, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223812941349434, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.The Second Affiliated School of Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang Province, China), AuthorCompanyExt(id=1325223812958126652, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223812941349434, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.浙江中医药大学第二临床医学院,浙江 杭州 310053)])]), Author(id=1325223813918622290, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223814027674196, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, authorId=1325223813918622290, language=EN, stringName=Chan HUANG, firstName=Chan, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.Nanjing Medical University, Nanjing 211166, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223814170280533, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, authorId=1325223813918622290, language=CN, stringName=黄婵, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.南京医科大学,江苏 南京 211166, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223813046207037, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, xref=2., ext=[AuthorCompanyExt(id=1325223813054595646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813046207037, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Nanjing Medical University, Nanjing 211166, Jiangsu Province, China), AuthorCompanyExt(id=1325223813062984255, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813046207037, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.南京医科大学,江苏 南京 211166)])]), Author(id=1325223814275138135, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223814497436249, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, authorId=1325223814275138135, language=EN, stringName=Yuwei LU, firstName=Yuwei, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
3, address=
3.Graduate Training Base of Wenzhou Medical University, Wenzhou 325035, Zhejiang Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223814589710938, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, authorId=1325223814275138135, language=CN, stringName=陆雨薇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
3, address=
3.温州医科大学研究生培养基地,浙江 温州 325035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223813138481728, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, xref=3., ext=[AuthorCompanyExt(id=1325223813146870337, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813138481728, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
3.Graduate Training Base of Wenzhou Medical University, Wenzhou 325035, Zhejiang Province, China), AuthorCompanyExt(id=1325223813159453250, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813138481728, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
3.温州医科大学研究生培养基地,浙江 温州 325035)])]), Author(id=1325223814904283740, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223815017529950, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, authorId=1325223814904283740, language=EN, stringName=Xinghao JIN, firstName=Xinghao, middleName=null, lastName=JIN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
4a, address=
4a.Department of Rheumatology and Immunology,Children's Hospital of Zhejiang University, Hangzhou 310052, Zhejiang Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223815336297055, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, authorId=1325223814904283740, language=CN, stringName=金星昊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
4a, address=
4a.浙江大学医学院附属儿童医院风湿免疫科,浙江 杭州 310052, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223813276893763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, xref=4a., ext=[AuthorCompanyExt(id=1325223813285282372, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813276893763, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
4a.Department of Rheumatology and Immunology,Children's Hospital of Zhejiang University, Hangzhou 310052, Zhejiang Province, China), AuthorCompanyExt(id=1325223813293670981, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813276893763, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
4a.浙江大学医学院附属儿童医院风湿免疫科,浙江 杭州 310052)])]), Author(id=1325223815420183137, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223815512457827, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, authorId=1325223815420183137, language=EN, stringName=Zibin BU, firstName=Zibin, middleName=null, lastName=BU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
4b, address=
4b.Department of Hematology,Children's Hospital of Zhejiang University, Hangzhou 310052, Zhejiang Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223815608926820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, authorId=1325223815420183137, language=CN, stringName=卜梓斌, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
4b, address=
4b.浙江大学医学院附属儿童医院血液科,浙江 杭州 310052, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223813381751366, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, xref=4b., ext=[AuthorCompanyExt(id=1325223813406917191, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813381751366, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
4b.Department of Hematology,Children's Hospital of Zhejiang University, Hangzhou 310052, Zhejiang Province, China), AuthorCompanyExt(id=1325223813427888712, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813381751366, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
4b.浙江大学医学院附属儿童医院血液科,浙江 杭州 310052)])]), Author(id=1325223817349562982, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223817538306664, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, authorId=1325223817349562982, language=EN, stringName=Wei ZHOU, firstName=Wei, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
4c, *, address=
4c.Department of Nephrology, Children's Hospital of Zhejiang University, Hangzhou 310052, Zhejiang Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223817844490857, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, authorId=1325223817349562982, language=CN, stringName=周维, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
4c, *, address=
4c.浙江大学医学院附属儿童医院肾内科,浙江 杭州 310052, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223813511774793, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, xref=4c., ext=[AuthorCompanyExt(id=1325223813520163402, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813511774793, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
4c.Department of Nephrology, Children's Hospital of Zhejiang University, Hangzhou 310052, Zhejiang Province, China), AuthorCompanyExt(id=1325223813528552011, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813511774793, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
4c.浙江大学医学院附属儿童医院肾内科,浙江 杭州 310052)])])], keywords=[Keyword(id=1325223818117120618, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, language=EN, orderNo=1, keyword=chimeric antigen receptor T cell therapy), Keyword(id=1325223818268115563, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, language=EN, orderNo=2, keyword=pediatric disease), Keyword(id=1325223818448470636, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, language=EN, orderNo=3, keyword=tumorous disease), Keyword(id=1325223818557522541, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, language=EN, orderNo=4, keyword=autoimmune disease), Keyword(id=1325223818687545966, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, language=CN, orderNo=1, keyword=嵌合抗原受体T细胞治疗), Keyword(id=1325223818788209263, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, language=CN, orderNo=2, keyword=儿童疾病), Keyword(id=1325223818863706736, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, language=CN, orderNo=3, keyword=肿瘤性疾病), Keyword(id=1325223819098587761, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, language=CN, orderNo=4, keyword=自身免疫性疾病)], refs=[Reference(id=1325223819257971314, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=NUMBENJAPON T, SERRANO LM, CHANG WC,
et al. Antigen-independent and antigen-dependent methods to numerically expand CD19-specific CD8
+ cells[J]. Exp Hematol, 2007, 35(7):1083-1090., articleTitle=null, refAbstract=null), Reference(id=1325223819341857395, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=ALBELDA SM. CAR T cell therapy for patients with solid tumours:key lessons to learn and unlearn[J]. Nat Rev Clin Oncol, 2024, 21(1):47-66., articleTitle=null, refAbstract=null), Reference(id=1325223819450909300, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=USCANGA-PALOMEQUE AC, CHAVEZ-ESCAMILLA AK, ALVIZO-BAEZ CA,
et al. CAR-T cell therapy:from the shop to cancer therapy[J]. Int J Mol Sci, 2023, 24(21):15688., articleTitle=null, refAbstract=null), Reference(id=1325223819593515637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=GUPTA S, SIMIC M, SAGAN SA,
et al. CAR-T cell-mediated B-cell depletion in central nervous system autoimmunity[J]. Neurol Neuroimmunol Neuroinflamm,2023, 10(2):e200080., articleTitle=null, refAbstract=null), Reference(id=1325223819706761846, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=SADELAIN M, BRENTJENS R, RIVIERE I. The basic principles of chimeric antigen receptor design[J]. Cancer Discov, 2013, 3(4):388-398., articleTitle=null, refAbstract=null), Reference(id=1325223819824202359, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=LEVINE BL, MISKIN J, WONNACOTT K,
et al. Global manufacturing of CAR T cell therapy[J]. Mol Ther Methods Clin Dev, 2017, 4:92-101., articleTitle=null, refAbstract=null), Reference(id=1325223819903894136, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=GHASSEMI S, DURGIN JS, NUNEZ-CRUZ S,
et al. Rapid manufacturing of non-activated potent CAR T cells[J]. Nat Biomed Eng, 2022, 6(2):118-128., articleTitle=null, refAbstract=null), Reference(id=1325223819996168825, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=ESHHAR Z, WAKS T, GROSS G,
et al. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors[J]. Proc Natl Acad Sci USA, 1993, 90(2):720-724., articleTitle=null, refAbstract=null), Reference(id=1325223820096832122, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=ROSENBERG SA, PACKARD BS, AEBERSOLD PM,
et al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report[J]. N Engl J Med, 1988, 319(25):1676-1680., articleTitle=null, refAbstract=null), Reference(id=1325223821850051195, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=DENLINGER N, BOND D, JAGLOWSKI S. CAR T-cell therapy for B-cell lymphoma[J]. Curr Probl Cancer, 2022,46(1):100826., articleTitle=null, refAbstract=null), Reference(id=1325223822001046140, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=LI S, ZHANG J, WANG M,
et al. Treatment of acute lymphoblastic leukaemia with the second generation of CD19 CAR-T containing either CD28 or 4-1BB[J]. Br J Haematol,2018, 181(3):360-371., articleTitle=null, refAbstract=null), Reference(id=1325223822231732861, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHONG XS, MATSUSHITA M, PLOTKIN J,
et al. Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI3kinase/AKT/Bcl-XL activation and CD8
+ T cell-mediated tumor eradication[J]. Mol Ther, 2010,18(2):413-420., articleTitle=null, refAbstract=null), Reference(id=1325223822315618942, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=CHMIELEWSKI M, ABKEN H. TRUCKs:the fourth generation of CARs[J]. Expert Opin Biol Ther, 2015, 15(8):1145-1154., articleTitle=null, refAbstract=null), Reference(id=1325223822470808191, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=TANG L, PAN S, WEI X,
et al. Arming CAR-T cells with cytokines and more:innovations in the fourth-generation CAR-T development[J]. Mol Ther, 2023, 31(11):3146-3162., articleTitle=null, refAbstract=null), Reference(id=1325223822558888576, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=KAGOYA Y, TANAKA S, GUO T,
et al. A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects[J]. Nat Med, 2018,24(3):352-359., articleTitle=null, refAbstract=null), Reference(id=1325223822655357569, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=KAKAJE A, ALHALABI MM, GHAREEB A,
et al. Rates and trends of childhood acute lymphoblastic leukaemia:an epidemiology study[J]. Sci Rep, 2020, 10(1):6756., articleTitle=null, refAbstract=null), Reference(id=1325223822869267074, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=SIEGEL RL, MILLER KD, FUCHS HE,
et al. Cancer statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1):7-33., articleTitle=null, refAbstract=null), Reference(id=1325223822986707587, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=TERWILLIGER T, ABDUL-HAY M. Acute lymphoblastic leukemia:a comprehensive review and 2017 update[J].Blood Cancer J, 2017, 7(6):e577., articleTitle=null, refAbstract=null), Reference(id=1325223823112536708, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=BADAR T, SHAH NN. Chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia[J]. Curr Treat Options Oncol, 2020, 21(2):16., articleTitle=null, refAbstract=null), Reference(id=1325223823305474693, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=LEE DW, KOCHENDERFER JN, STETLER-STEVENSON M,
et al. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults:a phase 1 dose-escalation trial[J]. Lancet, 2015,385(9967):517-528., articleTitle=null, refAbstract=null), Reference(id=1325223823418720902, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=MAUDE SL, FREY N, SHAW PA,
et al. Chimeric antigen receptor T cells for sustained remissions in leukemia[J]. N Engl J Med, 2014, 371(16):1507-1517., articleTitle=null, refAbstract=null), Reference(id=1325223823527772807, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=LEMAL R, TOURNILHAC O. State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019[J].J Immunother Cancer, 2019, 7(1):202., articleTitle=null, refAbstract=null), Reference(id=1325223823825568392, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=SCHUSTER SJ, BISHOP MR, TAM CS,
et al.Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma[J]. N Engl J Med, 2019, 380(1):45-56., articleTitle=null, refAbstract=null), Reference(id=1325223824123363977, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=PARK JH, RIVIERE I, GONEN M,
et al. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia[J]. N Engl J Med, 2018, 378(5):449-459., articleTitle=null, refAbstract=null), Reference(id=1325223824211444362, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=GARDNER R, WU D, CHERIAN S,
et al. Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy[J].Blood, 2016, 127(20):2406-2410., articleTitle=null, refAbstract=null), Reference(id=1325223824295330443, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=MARTINO M, ALATI C, CANALE FA,
et al. A review of clinical outcomes of CAR T-cell therapies for B-acute lymphoblastic leukemia[J]. Int J Mol Sci, 2021, 22(4):2150., articleTitle=null, refAbstract=null), Reference(id=1325223824421159564, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=SALVARIS R, FEDELE PL. Targeted therapy in acute lymphoblastic leukaemia[J]. J Pers Med, 2021, 11(8):715., articleTitle=null, refAbstract=null), Reference(id=1325223824496657037, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=YUEN S, PHILLIPS TJ, BANNERJI R,
et al. Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma[J].Am J Hematol, 2024, 99(7):1281-1289., articleTitle=null, refAbstract=null), Reference(id=1325223824605708942, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=SHAH NN, HIGHFILL SL, SHALABI H,
et al. CD4/CD8 T-cell selection affects chimeric antigen receptor(CAR)T-cell potency and toxicity:updated results from a phaseⅠanti-CD22 CAR T-cell trial[J]. J Clin Oncol, 2020, 38(17):1938-1950., articleTitle=null, refAbstract=null), Reference(id=1325223826304402065, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=BONGIOVANNI D, SACCOMANI V, PIOVAN E.Aberrant signaling pathways in T-cell acute lymphoblastic leukemia[J]. Int J Mol Sci, 2017, 18(9):1904., articleTitle=null, refAbstract=null), Reference(id=1325223826421842578, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=TEACHEY DT, HUNGER SP. Anti-CD7 CAR T cells for T-ALL:impressive early-stage efficacy[J]. Nat Rev Clin Oncol, 2021, 18(11):677-678., articleTitle=null, refAbstract=null), Reference(id=1325223826505728659, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=MACIOCIA PM, WAWRZYNIECKA PA, PHILIP B,
et al.Targeting the T cell receptor beta-chain constant region for immunotherapy of T cell malignancies[J]. Nat Med, 2017,23(12):1416-1423., articleTitle=null, refAbstract=null), Reference(id=1325223826606391956, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=PAN J, TAN Y, WANG G,
et al. Donor-derived CD7 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia:first-in-human, phaseⅠtrial[J]. J Clin Oncol,2021, 39(30):3340-3351., articleTitle=null, refAbstract=null), Reference(id=1325223826698666645, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=SCOTLANDI K, MANARA MC, HATTINGER CM,
et al.Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcoma[J]. Eur J Cancer, 2005,41(9):1349-1361., articleTitle=null, refAbstract=null), Reference(id=1325223826807718550, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=MAJZNER RG, THERUVATH JL, NELLAN A,
et al. CAR T cells targeting B7-H3, a pan-cancer antigen, demonstrate potent preclinical activity against pediatric solid tumors and brain tumors[J]. Clin Cancer Res, 2019, 25(8):2560-2574., articleTitle=null, refAbstract=null), Reference(id=1325223826899993239, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=HUANG G, YU L, COOPER LJ,
et al. Genetically modified T cells targeting interleukin-11 receptor alpha-chain kill human osteosarcoma cells and induce the regression of established osteosarcoma lung metastases[J]. Cancer Res,2012, 72(1):271-281., articleTitle=null, refAbstract=null), Reference(id=1325223826992267928, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=HSU K, MIDDLEMISS S, SALETTA F,
et al. Chimeric antigen receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours[J]. Cancer Gene Ther, 2021, 28(3-4):321-334., articleTitle=null, refAbstract=null), Reference(id=1325223827097125529, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=MENSALI N, KOKSAL H, JOAQUINA S,
et al. ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma[J]. Nat Commun, 2023, 14(1):3375., articleTitle=null, refAbstract=null), Reference(id=1325223827185205914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=AHMED N, BRAWLEY VS, HEGDE M,
et al. Human epidermal growth factor receptor 2(HER2) -specific chimeric antigen receptor-modified T cells for the immunotherapy of HER2-positive sarcoma[J]. J Clin Oncol, 2015, 33(15):1688-1696., articleTitle=null, refAbstract=null), Reference(id=1325223827273286299, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=CHULANETRA M, MORCHANG A, SAYOUR E,
et al. GD2 chimeric antigen receptor modified T cells in synergy with sub-toxic level of doxorubicin targeting osteosarcomas[J]. Am J Cancer Res, 2020, 10(2):674-687., articleTitle=null, refAbstract=null), Reference(id=1325223827403309724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=TALBOT LJ, CHABOT A, ROSS AB,
et al. Redirecting B7-H3. CAR T cells to chemokines expressed in osteosarcoma enhances homing and antitumor activity in preclinical models[J]. Clin Cancer Res, 2024, 30(19):4434-4449., articleTitle=null, refAbstract=null), Reference(id=1325223827487195805, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=HUANG X, PARK H, GREENE J,
et al. IGF1R- and ROR1-specific CAR T cells as a potential therapy for high risk sarcomas[J]. PLoS One, 2015, 10(7):e133152., articleTitle=null, refAbstract=null), Reference(id=1325223827554304670, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=ENGLISCH A, ALTVATER B, KAILAYANGIRI S,
et al. VEGFR2 as a target for CAR T cell therapy of Ewing sarcoma[J]. Pediatr Blood Cancer, 2020, 67(10):e28313., articleTitle=null, refAbstract=null), Reference(id=1325223827629802143, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=GONZALEZ E, BUI M, AHMED AA. IGF1R immunohistochemistry in Ewing's sarcoma as predictor of response to targeted therapy[J]. Int J Health Sci(Qassim),2020, 14(4):17-21., articleTitle=null, refAbstract=null), Reference(id=1325223827722076832, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=ZAFAR A, WANG W, LIU G,
et al. Molecular targeting therapies for neuroblastoma:progress and challenges[J].Med Res Rev, 2021, 41(2):961-1021., articleTitle=null, refAbstract=null), Reference(id=1325223827864683169, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=RICHARDS RM, SOTILLO E, MAJZNER RG. CAR T cell therapy for neuroblastoma[J]. Front Immunol, 2018, 9:2380., articleTitle=null, refAbstract=null), Reference(id=1325223827948569250, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=ROSSIG C, BOLLARD CM, NUCHTERN JG,
et al.Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes[J]. Int J Cancer, 2001, 94(2):228-236., articleTitle=null, refAbstract=null), Reference(id=1325223828049232547, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=PULE MA, SAVOLDO B, MYERS GD,
et al. Virus-specific T cells engineered to coexpress tumor-specific receptors:persistence and antitumor activity in individuals with neuroblastoma[J]. Nat Med, 2008, 14(11):1264-1270., articleTitle=null, refAbstract=null), Reference(id=1325223828149895844, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=LOUIS CU, SAVOLDO B, DOTTI G,
et al. Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma[J]. Blood,2011, 118(23):6050-6056., articleTitle=null, refAbstract=null), Reference(id=1325223828250559141, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=HECZEY A, LOUIS CU, SAVOLDO B,
et al. CAR T cells administered in combination with lymphodepletion and PD-1 inhibition to patients with neuroblastoma[J]. Mol Ther, 2017,25(9):2214-2224., articleTitle=null, refAbstract=null), Reference(id=1325223828326056614, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=STRAATHOF K, FLUTTER B, WALLACE R,
et al.Antitumor activity without on-target off-tumor toxicity of GD2-chimeric antigen receptor T cells in patients with neuroblastoma[J]. Sci Transl Med, 2020, 12(571):eabd6169., articleTitle=null, refAbstract=null), Reference(id=1325223828418331303, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=YU L, HUANG L, LIN D,
et al. GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients[J]. J Cancer Res Clin Oncol, 2022, 148(10):2643-2652., articleTitle=null, refAbstract=null), Reference(id=1325223828502217384, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=ANTONUCCI L, CANCIANI G, MASTRONUZZI A,
et al. CAR-T therapy for pediatric high-grade gliomas:peculiarities, current investigations and future strategies[J].Front Immunol, 2022, 13:867154., articleTitle=null, refAbstract=null), Reference(id=1325223828602880681, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=HAYDAR D, HOUKE H, CHIANG J,
et al. Cell-surface antigen profiling of pediatric brain tumors:B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery[J]. Neuro Oncol, 2021, 23(6):999-1011., articleTitle=null, refAbstract=null), Reference(id=1325223828674183850, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=MAJZNER RG, RAMAKRISHNA S, YEOM KW,
et al.GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas[J]. Nature, 2022, 603(7903):934-941., articleTitle=null, refAbstract=null), Reference(id=1325223828745487019, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=VITANZA NA, WILSON AL, HUANG W,
et al.Intraventricular B7-H3 CAR T cells for diffuse intrinsic pontine glioma:preliminary first-in-human bioactivity and safety[J]. Cancer Discov, 2023, 13(1):114-131., articleTitle=null, refAbstract=null), Reference(id=1325223828820984492, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=DONOVAN LK, DELAIDELLI A, JOSEPH SK,
et al.Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma[J]. Nat Med, 2020, 26(5):720-731., articleTitle=null, refAbstract=null), Reference(id=1325223828917453485, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=VITANZA NA, JOHNSON AJ, WILSON AL,
et al.Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors:an interim analysis[J]. Nat Med, 2021, 27(9):1544-1552., articleTitle=null, refAbstract=null), Reference(id=1325223829030699694, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[59], rfOrder=58, authorNames=null, journalName=null, refType=null, unstructuredReference=LIBES J, HOL J, NETO J,
et al. Pediatric renal tumor epidemiology:global perspectives, progress, and challenges[J]. Pediatr Blood Cancer, 2023, 70(Suppl 2):e30343., articleTitle=null, refAbstract=null), Reference(id=1325223829106197167, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[60], rfOrder=59, authorNames=null, journalName=null, refType=null, unstructuredReference=KULCZYCKA M, DERLATKA K, TASIOR J,
et al. CAR T-cell therapy in children with solid tumors[J]. J Clin Med,2023, 12(6):2326., articleTitle=null, refAbstract=null), Reference(id=1325223830813278896, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[61], rfOrder=60, authorNames=null, journalName=null, refType=null, unstructuredReference=FU Y, URBAN DJ, NANI RR,
et al. Glypican-3-specific antibody drug conjugates targeting hepatocellular carcinoma[J]. Hepatology, 2019, 70(2):563-576., articleTitle=null, refAbstract=null), Reference(id=1325223830901359281, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[62], rfOrder=61, authorNames=null, journalName=null, refType=null, unstructuredReference=STEFFIN D, GHATWAI N, MONTALBANO A,
et al.Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers[J]. Nature, 2025, 637(8047):940-946., articleTitle=null, refAbstract=null), Reference(id=1325223830989439666, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[63], rfOrder=62, authorNames=null, journalName=null, refType=null, unstructuredReference=ANNESLEY C. EGFR806 CAR T cell immunotherapy for recurrent/ refractory solid tumors in children and young adults[EB/OL]. Seattle:Seattle Children's Hospital,2024(2025-11-20)[2025-01-11]. https://clinicaltrials.gov/ct2/show/NCT03618381., articleTitle=null, refAbstract=null), Reference(id=1325223831077520051, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[64], rfOrder=63, authorNames=null, journalName=null, refType=null, unstructuredReference=ANNESLEY O. B7H3 CAR T cell immunotherapy for recurrent/refractory solid tumors in children and young adults[EB/OL]. Seattle:Seattle Children's Hospital, (2024-12-27)[2025-01-11]. https://clinicaltrials.gov/ct2/show/NCT04483778., articleTitle=null, refAbstract=null), Reference(id=1325223831165600436, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[65], rfOrder=64, authorNames=null, journalName=null, refType=null, unstructuredReference=MANRIQUE M, AKINBOLUE D, MADIGAN WP,
et al.Update on the treatment of retinoblastoma[J]. Neoreviews,2021, 22(7):e423-e437., articleTitle=null, refAbstract=null), Reference(id=1325223831253680821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[66], rfOrder=65, authorNames=null, journalName=null, refType=null, unstructuredReference=ANDERSCH L, RADKE J, KLAUS A,
et al. CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing[J]. Bio Med Central Cancer,2019, 19(1):895., articleTitle=null, refAbstract=null), Reference(id=1325223831362732726, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[67], rfOrder=66, authorNames=null, journalName=null, refType=null, unstructuredReference=SUJJITJOON J, SAYOUR E, TSAO ST,
et al. GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma - assessing tumor and T cell interaction[J].Transl Oncol, 2021, 14(2):100971., articleTitle=null, refAbstract=null), Reference(id=1325223831446618807, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[68], rfOrder=67, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG K, CHEN Y, AHN S,
et al. GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision[J]. Nat Cancer, 2020, 1(10):990-997., articleTitle=null, refAbstract=null), Reference(id=1325223831530504888, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[69], rfOrder=68, authorNames=null, journalName=null, refType=null, unstructuredReference=LINCH M, MIAH AB, THWAY K,
et al. Systemic treatment of soft-tissue sarcoma-gold standard and novel therapies[J].Nat Rev Clin Oncol, 2014, 11(4):187-202., articleTitle=null, refAbstract=null), Reference(id=1325223831626973881, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[70], rfOrder=69, authorNames=null, journalName=null, refType=null, unstructuredReference=JIANG C, ZHAO W, QIN M,
et al. CD56-chimeric antigen receptor T-cell therapy for refractory/recurrent rhabdomyosarcoma:a 3.5-year follow-up case report[J].Medicine (Baltimore), 2019, 98(43):e17572., articleTitle=null, refAbstract=null), Reference(id=1325223831731831482, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[71], rfOrder=70, authorNames=null, journalName=null, refType=null, unstructuredReference=HEGDE M, JOSEPH SK, PASHANKAR F,
et al.Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma[J]. Nat Commun, 2020,11(1):3549., articleTitle=null, refAbstract=null), Reference(id=1325223831853466299, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[72], rfOrder=71, authorNames=null, journalName=null, refType=null, unstructuredReference=AHAMADA MM, JIA Y, WU X. Macrophage polarization and plasticity in systemic lupus erythematosus[J]. Front Immunol, 2021,12:734008., articleTitle=null, refAbstract=null), Reference(id=1325223831970906812, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[73], rfOrder=72, authorNames=null, journalName=null, refType=null, unstructuredReference=MACKENSEN A, MULLER F, MOUGIAKAKOS D,
et al.Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus[J]. Nat Med, 2022, 28(10):2124-2132., articleTitle=null, refAbstract=null), Reference(id=1325223832071570109, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[74], rfOrder=73, authorNames=null, journalName=null, refType=null, unstructuredReference=STOJKIC I, HARPER L, COSS S,
et al. CAR T cell therapy for refractory pediatric systemic lupus erythematosus:a new era of hope?[J]. Pediatr Rheumatol Online J, 2024, 22(1):72., articleTitle=null, refAbstract=null), Reference(id=1325223832163844798, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[75], rfOrder=74, authorNames=null, journalName=null, refType=null, unstructuredReference=Burki T. CAR T-cell therapy for SLE in children[J]. Lancet Rheumatol, 2024, doi:10.1016/S2665-9913(24)00098-5., articleTitle=null, refAbstract=null), Reference(id=1325223832277091007, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[76], rfOrder=75, authorNames=null, journalName=null, refType=null, unstructuredReference=WU JQ, LU MP, REED AM. Juvenile dermatomyositis:advances in clinical presentation, myositis-specific antibodies and treatment[J]. World J Pediatr, 2020, 16(1):31-43., articleTitle=null, refAbstract=null), Reference(id=1325223832381948608, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[77], rfOrder=76, authorNames=null, journalName=null, refType=null, unstructuredReference=CASTILLO RL, HASHEMI K, RAINONE E,
et al. From traditional to targeted:the changing trajectory of therapies in dermatomyositis[J]. Curr Opin Rheumatol, 2024, 36(6):438-444., articleTitle=null, refAbstract=null), Reference(id=1325223832474223297, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[78], rfOrder=77, authorNames=null, journalName=null, refType=null, unstructuredReference=NICOLAI R, MERLI P, MORAN AP,
et al. Autologous CD19-targeting CAR T cells in a patient with refractory juvenile dermatomyositis[J]. Arthritis Rheumatol, 2024,76(10):1560-1565., articleTitle=null, refAbstract=null), Reference(id=1325223832583275202, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[79], rfOrder=78, authorNames=null, journalName=null, refType=null, unstructuredReference=ARMEFTIS C, GRATZIOU C, SIAFAKAS N,
et al. An update on asthma diagnosis[J]. J Asthma, 2023, 60(12):2104-2110., articleTitle=null, refAbstract=null), Reference(id=1325223832683938499, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[80], rfOrder=79, authorNames=null, journalName=null, refType=null, unstructuredReference=VULTAGGIO A, ACCINNO M, VIVARELLI E,
et al. Blood CD62L(low) inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab[J]. Allergy,2023,78(12):3154-3165., articleTitle=null, refAbstract=null), Reference(id=1325223832776213188, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[81], rfOrder=80, authorNames=null, journalName=null, refType=null, unstructuredReference=JIN G, LIU Y, WANG L,
et al. A single infusion of engineered long-lived and multifunctional T cells confers durable remission of asthma in mice[J]. Nat Immunol, 2024, 25(6):1059-1072., articleTitle=null, refAbstract=null), Reference(id=1325223832876876485, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[82], rfOrder=81, authorNames=null, journalName=null, refType=null, unstructuredReference=李本尚, 杨柳. 儿童CAR-T细胞治疗的挑战与展望[J]. 临床儿科杂志, 2024, 42(7):573-577., articleTitle=null, refAbstract=null), Reference(id=1325223832973345478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[83], rfOrder=82, authorNames=null, journalName=null, refType=null, unstructuredReference=le CACHEUX C, COUTURIER A, SORTAIS C,
et al.Features and outcomes of patients admitted to the ICU for chimeric antigen receptor T cell-related toxicity:a French multicentre cohort[J]. Ann Intensive Care, 2024, 14(1):20., articleTitle=null, refAbstract=null), Reference(id=1325223833082397383, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[84], rfOrder=83, authorNames=null, journalName=null, refType=null, unstructuredReference=HINES MR, KEENAN C, MARON AG,
et al.Hemophagocytic lymphohistiocytosis-like toxicity(carHLH)after CD19-specific CAR T-cell therapy[J]. Br J Haematol,2021, 194(4):701-707., articleTitle=null, refAbstract=null), Reference(id=1325223833178866376, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[85], rfOrder=84, authorNames=null, journalName=null, refType=null, unstructuredReference=SONG Z, TU D, TANG G,
et al. Hemophagocytic lymphohistiocytosis and disseminated intravascular coagulation are underestimated, but fatal adverse events in chimeric antigen receptor T-cell therapy[J]. Haematologica,2023, 108(8):2067-2079., articleTitle=null, refAbstract=null), Reference(id=1325223833287918281, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[86], rfOrder=85, authorNames=null, journalName=null, refType=null, unstructuredReference=KADAUKE S, MYERS RM, LI Y,
et al. Risk-adapted preemptive tocilizumab to prevent severe cytokine release syndrome after CTL019 for pediatric B-cell acute lymphoblastic leukemia:a prospective clinical trial[J]. J Clin Oncol, 2021, 39(8):920-930., articleTitle=null, refAbstract=null), Reference(id=1325223833392775882, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[87], rfOrder=86, authorNames=null, journalName=null, refType=null, unstructuredReference=SHEN J, HU R, LIN A,
et al. Characterization of second primary malignancies post CAR T-cell therapy:real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase[J]. EClinicalMedicine, 2024, 73:102684., articleTitle=null, refAbstract=null), Reference(id=1325223833485050571, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[88], rfOrder=87, authorNames=null, journalName=null, refType=null, unstructuredReference=HERNANDEZ I, PRASAD V, GELLAD WF. Total costs of chimeric antigen receptor T-cell immunotherapy[J]. J Am Med Assoc Oncol, 2018, 4(7):994-996., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1325223812941349434, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, xref=1., ext=[AuthorCompanyExt(id=1325223812949738043, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223812941349434, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.The Second Affiliated School of Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang Province, China), AuthorCompanyExt(id=1325223812958126652, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223812941349434, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.浙江中医药大学第二临床医学院,浙江 杭州 310053)]), AuthorCompany(id=1325223813046207037, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, xref=2., ext=[AuthorCompanyExt(id=1325223813054595646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813046207037, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Nanjing Medical University, Nanjing 211166, Jiangsu Province, China), AuthorCompanyExt(id=1325223813062984255, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813046207037, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.南京医科大学,江苏 南京 211166)]), AuthorCompany(id=1325223813138481728, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, xref=3., ext=[AuthorCompanyExt(id=1325223813146870337, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813138481728, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
3.Graduate Training Base of Wenzhou Medical University, Wenzhou 325035, Zhejiang Province, China), AuthorCompanyExt(id=1325223813159453250, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813138481728, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
3.温州医科大学研究生培养基地,浙江 温州 325035)]), AuthorCompany(id=1325223813276893763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, xref=4a., ext=[AuthorCompanyExt(id=1325223813285282372, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813276893763, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
4a.Department of Rheumatology and Immunology,Children's Hospital of Zhejiang University, Hangzhou 310052, Zhejiang Province, China), AuthorCompanyExt(id=1325223813293670981, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813276893763, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
4a.浙江大学医学院附属儿童医院风湿免疫科,浙江 杭州 310052)]), AuthorCompany(id=1325223813381751366, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, xref=4b., ext=[AuthorCompanyExt(id=1325223813406917191, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813381751366, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
4b.Department of Hematology,Children's Hospital of Zhejiang University, Hangzhou 310052, Zhejiang Province, China), AuthorCompanyExt(id=1325223813427888712, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813381751366, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
4b.浙江大学医学院附属儿童医院血液科,浙江 杭州 310052)]), AuthorCompany(id=1325223813511774793, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, xref=4c., ext=[AuthorCompanyExt(id=1325223813520163402, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813511774793, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
4c.Department of Nephrology, Children's Hospital of Zhejiang University, Hangzhou 310052, Zhejiang Province, China), AuthorCompanyExt(id=1325223813528552011, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223810647065142, companyId=1325223813511774793, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
4c.浙江大学医学院附属儿童医院肾内科,浙江 杭州 310052)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.04.012, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.04.012, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2026.04.012, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2026.04.012, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1775750400000, fullTextJson=null, articleText=null, reference=null)